Literature DB >> 1663470

[Incidence of congenital infections].

K Friese1, M Beichert, H Hof, W Weikel, D Falke, R Sickinger, F Melchert.   

Abstract

The discussions on the pros and cons of obstetric screening for connatal infections have been going on for years. We, therefore, conducted a prevalence study of the most common connatal infections. HIV infection, rubella and syphilis were not subjects of this study. We analysed the relevance of these infections in 512 pregnant women and their newborn infants at the moment of delivery. Further serological tests were run three months post partum, if necessary even for a longer period. Cytomegaly IgG antibodies were found in 46% of the examined women, IgM antibodies in 1.3%. Women under the age of twenty and women of low social standing showed the highest rate of prevalence of infection with CMV. The prevalence of IgG antibodies against parvovirus B 19 was 29%. In 10 mothers, positive IgM titers were found at the time of delivery. In all these women, pregnancies had been uneventful. However, 9 mothers exhibited a significantly raised abortion rate within the last 20 months before delivery. 7 of 512 women turned out to be HBs antigen carriers, 3 women and their babies were anti-HCV positive. The prevalence of toxoplasmosis IgG antibodies was 36%, of IgM antibodies 5.3%. By further investigation (Toxo ISAGA, Toxo IgA) we were able to detect one child with connatal toxoplasmosis. We conclude, that screening for parvovirus B 19 and hepatitis C is required only, if there are contact or clinical hints that the patients might have acquired either one of these infections. But we postulate, that a routine screening programme for hepatitis B and toxoplasmosis should be carried out in all pregnant women.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1663470     DOI: 10.1055/s-2008-1026231

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  4 in total

1.  Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Authors:  Gisela Enders; Anja Daiminger; Lisa Lindemann; Frank Knotek; Ursula Bäder; Simone Exler; Martin Enders
Journal:  Med Microbiol Immunol       Date:  2012-03-08       Impact factor: 3.402

2. 

Authors:  P Holhlfeld
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

3.  Assessment of Balamuthia mandrillaris-specific serum antibody concentrations by flow cytometry.

Authors:  Albrecht F Kiderlen; Elke Radam; Phiroze S Tata
Journal:  Parasitol Res       Date:  2008-11-28       Impact factor: 2.289

4.  Thirty years of CMV seroprevalence-a longitudinal analysis in a German university hospital.

Authors:  Sebastian Hoehl; Annemarie Berger; Sandra Ciesek; Holger F Rabenau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-27       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.